EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Jiebai-Qingfei San Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Modulating Inflammation, Oxidative Stress, and Macrophage-Associated Phenotypes

Xiangwen Deng, Jin He, Lin Yu, Yaming Yu, Kexin Fang, Yang Yang, Deyun Wang

Pharmaceuticals · 18.11.2026 · 19 (11) · 1835

DOI: 10.3390/ph19111835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 18.11.2026. Verfasst von Xiangwen Deng und 6 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, National Key Research and Development Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Jiebai-Qingfei San (JBQFS) is a seven-herb traditional Chinese veterinary formulation developed for respiratory disorders. However, its pharmacological effects against acute pulmonary inflammation and the associated molecular responses remain unclear. This study examined the protective activity of JBQFS in LPS-induced acute lung injury (ALI) and characterized the biological responses associated with treatment.

Methods

The chemical profile of JBQFS was characterized by ultra-high-performance liquid chromatography coupled with high-resolution tandem mass spectrometry (UHPLC-HRMS/MS), and two representative marker compounds were quantified by high-performance liquid chromatography (HPLC). Lung transcriptomic analysis followed by qRT-PCR validation was performed to identify inflammation-related transcriptional responses. The effects of JBQFS were further examined in the murine alveolar macrophage cell line MH-S following LPS stimulation.

Results

JBQFS pretreatment ameliorated LPS-induced alterations in respiratory parameters and attenuated histopathological injury, reduced inflammatory cytokine levels, and improved oxidative stress-related parameters. It also modulated macrophage-associated markers in lung tissue. Transcriptomic and qRT-PCR analyses showed that JBQFS administration was associated with changes in inflammation-related transcriptional responses, including genes related to TLR4/MyD88/NF-κB signaling. In MH-S cells, JBQFS reduced inflammatory mediator production and intracellular ROS and Ca2+ levels, preserved mitochondrial membrane potential, and modulated CD80, CD86, and CD206 expression.

Conclusions

Pretreatment with JBQFS protected against LPS-induced ALI and was associated with reduced inflammation and oxidative stress, as well as modulation of macrophage-associated inflammatory phenotypes. These findings support further investigation of JBQFS for inflammatory respiratory disorders.

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program

Zitieren

APA

Deng, X., He, J., Yu, L., Yu, Y., Fang, K., Yang, Y., & Wang, D. (2026). Jiebai-Qingfei San Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Modulating Inflammation, Oxidative Stress, and Macrophage-Associated Phenotypes. Pharmaceuticals, 19(11), 1835. https://doi.org/10.3390/ph19111835

Vancouver

Deng X, He J, Yu L, Yu Y, Fang K, Yang Y, et al. Jiebai-Qingfei San Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Modulating Inflammation, Oxidative Stress, and Macrophage-Associated Phenotypes. Pharmaceuticals. 2026;19(11):1835. doi:10.3390/ph19111835

BibTeX
@article{Deng2026,
  author = {Deng, Xiangwen and He, Jin and Yu, Lin and Yu, Yaming and Fang, Kexin and Yang, Yang and Wang, Deyun},
  title = {Jiebai-Qingfei San Protects Against Lipopolysaccharide-Induced Acute Lung Injury by Modulating Inflammation, Oxidative Stress, and Macrophage-Associated Phenotypes},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1835},
  doi = {10.3390/ph19111835}
}
Kostenlos starten →